Associate Scientist, Product and Analytical Sciences at Bristol-Myers Squibb

Seattle, Washington, United States

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, Cell TherapyIndustries

Requirements

Bachelor’s degree with a focus on life sciences with 1+ years of industry experience
Basic knowledge of methods used to characterize cellular and viral material
Specific knowledge of flow cytometry, molecular biology and functional cell-based assays is desirable
Previous experience with assay automation is desired
Experience with ELN systems is preferred
Motivation and drive to acquire new skills and knowledge
Willingness to work in a regulated industrial environment
Excellent verbal, written, and oral communication skills

Responsibilities

Execute routine assays in support of multiple early and late-stage development efforts
Record results in an electronic lab notebook (ELN) for review and release
Gain proficiency in multiple methods
Act as a reviewer of ELN data entries
Present results to an audience of peers and program stakeholders as needed
Contribute to laboratory operations including reagent preparation, consumables restocking, and general cleanup/lab duties
Reinforce safe workplace practices in accordance with company and OSHA policies/procedures

Skills

flow cytometry

molecular assays

cell-based assays

analytical testing

ELN

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free